UniQure Net Income 2013-2021 | QURE

UniQure net income from 2013 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
UniQure Annual Net Income
(Millions of US $)
2020 $-125
2019 $-124
2018 $-83
2017 $-79
2016 $-73
2015 $-82
2014 $-50
2013 $-36
2012 $-19
UniQure Quarterly Net Income
(Millions of US $)
2021-06-30 $399
2021-03-31 $-42
2020-12-31 $-1
2020-09-30 $-54
2020-06-30 $-43
2020-03-31 $-28
2019-12-31 $-41
2019-09-30 $-24
2019-06-30 $-31
2019-03-31 $-28
2018-12-31 $-22
2018-09-30 $-22
2018-06-30 $-21
2018-03-31 $-19
2017-12-31 $-27
2017-09-30 $-10
2017-06-30 $-21
2017-03-31 $-20
2016-12-31 $-15
2016-09-30 $-15
2016-06-30 $-21
2016-03-31 $-22
2015-12-31 $-19
2015-09-30 $-29
2015-06-30 $-21
2015-03-31 $-14
2014-12-31 $-0
2014-09-30 $-11
2014-06-30 $-12
2014-03-31 $-11
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.386B $0.038B
UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00